Selective and Quantitative Detection of Influenza Virus Proteins in Commercial Vaccines Using Two-Dimensional High-Performance Liquid Chromatography and Fluorescence Detection
- 16 March 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 79 (8) , 3164-3172
- https://doi.org/10.1021/ac0621120
Abstract
In this work, we report on the applicability of two-dimensional high-performance liquid chromatography (2D-HPLC) for the comprehensive characterization of inactivated influenza vaccine proteins. This novel procedure features minimal sample treatment and combines the on-line coupling of size exclusion HPLC to reversed-phase HPLC. A comparative analysis of commercial vaccines from three different manufacturers showed the method to be highly selective by providing characteristic reproducible chromatographic profiles for each vaccine. In addition, the method provided enhanced sensitivity for most constituents as a result of the use of native fluorescence detection in the reversed-phase HPLC step. The limits of detection (at a signal-to-noise ratio of >3) for hemagglutinin (HA) antigens were 105 and 172 ng/mL for influenza A/New Caledonia/20/99 and B/Jiangsu/10/2003 strains, respectively. The potential of this 2D-HPLC procedure in terms of quantitative antigen analysis was assessed by determination of the HA content of commercial vaccines. Results provided very good correlation with nominal HA values. The reproducibility (RSD) of the whole procedure was also evaluated and was found to be better than 2 and 3% for calculated antigen concentrations expressed as micrograms of HA per milliliter in commercial vaccines for samples of the same lot (n = 5) or different lots (n = 3), respectively. In addition, it allowed the selective detection of several influenza constituents including nucleoproteins from type A and B viruses and the highly hydrophobic matrix protein 1 from both virus strains.Keywords
This publication has 12 references indexed in Scilit:
- Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columnsJournal of Chromatography A, 2006
- A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometryProteomics, 2006
- Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatographyVaccine, 2005
- Optimization of Two-Dimensional Off-Line LC/MS Separations To Improve Resolution of Complex Proteomic SamplesAnalytical Chemistry, 2004
- Combined Results from Solution Studies on Intact Influenza Virus M1 Protein and from a New Crystal Form of Its N-Terminal Domain Show That M1 Is an Elongated MonomerVirology, 2001
- Antigenic Surveillance of the Influenza Virus by Mass SpectrometryBiochemistry, 1999
- Morphological and biochemical characterization of influenza vaccines commercially available in the United KingdomVaccine, 1994
- Concepts and comparisons in multidimensional separationJournal of High Resolution Chromatography, 1987
- Isolation of influenza viral proteins by size-exclusion and ion-exchange high-performance liquid chromatography: the influence of conditions on separationJournal of Chromatography A, 1984
- Gradient optimization principles in reversed-phase high-performance liquid chromatography and the separation of influenza virus componentsJournal of Chromatography A, 1983